175 related articles for article (PubMed ID: 32289177)
1. A glimpse at growth hormone-releasing hormone cosmos.
Barabutis N
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1632-1634. PubMed ID: 32289177
[TBL] [Abstract][Full Text] [Related]
2. GHRH Antagonists Protect Against Hydrogen Peroxide-Induced Breakdown of Brain Microvascular Endothelium Integrity.
Barabutis N; Akhter MS; Uddin MA; Kubra KT; Schally AV
Horm Metab Res; 2020 May; 52(5):336-339. PubMed ID: 32403147
[TBL] [Abstract][Full Text] [Related]
3. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
[TBL] [Abstract][Full Text] [Related]
5. GHRH antagonists support lung endothelial barrier function.
Uddin MA; Akhter MS; Singh SS; Kubra KT; Schally AV; Jois S; Barabutis N
Tissue Barriers; 2019; 7(4):1669989. PubMed ID: 31578921
[TBL] [Abstract][Full Text] [Related]
6. Growth Hormone-Releasing Hormone in Endothelial Inflammation.
Barabutis N; Akhter MS; Kubra KT; Jackson K
Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36503995
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
[TBL] [Abstract][Full Text] [Related]
8. P53, GHRH, inflammation and cancer.
Barabutis N; Schally AV; Siejka A
EBioMedicine; 2018 Nov; 37():557-562. PubMed ID: 30344124
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
Wang H; Zhang X; Vidaurre I; Cai R; Sha W; Schally AV
Int J Cancer; 2018 Jun; 142(11):2394-2404. PubMed ID: 29435973
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCδ-mediated activation of p53/p21.
Wu HM; Schally AV; Cheng JC; Zarandi M; Varga J; Leung PC
Cancer Lett; 2010 Dec; 298(1):16-25. PubMed ID: 20630651
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
Akhter MS; Kubra KT; Barabutis N
Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
[TBL] [Abstract][Full Text] [Related]
12. P53 versus inflammation: an update.
Kubra KT; Akhter MS; Uddin MA; Barabutis N
Cell Cycle; 2020 Jan; 19(2):160-162. PubMed ID: 31880200
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Jungwirth A; Schally AV; Pinski J; Groot K; Armatis P; Halmos G
Proc Natl Acad Sci U S A; 1997 May; 94(11):5810-3. PubMed ID: 9159156
[TBL] [Abstract][Full Text] [Related]
14. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone.
Akhter MS; Barabutis N
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22879. PubMed ID: 34369038
[TBL] [Abstract][Full Text] [Related]
15. Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers.
Perez R; Schally AV; Vidaurre I; Rincon R; Block NL; Rick FG
Oncotarget; 2012 Sep; 3(9):988-97. PubMed ID: 22941871
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines.
Barabutis N; Siejka A; Schally AV
Int J Oncol; 2010 May; 36(5):1285-9. PubMed ID: 20372804
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
[TBL] [Abstract][Full Text] [Related]
19. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G
Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186
[TBL] [Abstract][Full Text] [Related]
20. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z
J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
